Literature DB >> 21136595

Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.

Xuefeng B Ling1, Jane L Park, Tanya Carroll, Khoa D Nguyen, Kenneth Lau, Claudia Macaubas, Edward Chen, Tzielan Lee, Christy Sandborg, Diana Milojevic, John T Kanegaye, Susanna Gao, Jane Burns, James Schilling, Elizabeth D Mellins.   

Abstract

Systemic juvenile idiopathic arthritis (SJIA) is a chronic arthritis of children characterized by a combination of arthritis and systemic inflammation. There is usually non-specific laboratory evidence of inflammation at diagnosis but no diagnostic test. Normalized volumes from 89/889 2-D protein spots representing 26 proteins revealed a plasma pattern that distinguishes SJIA flare from quiescence. Highly discriminating spots derived from 15 proteins constitute a robust SJIA flare signature and show specificity for SJIA flare in comparison to active polyarticular juvenile idiopathic arthritis or acute febrile illness. We used 7 available ELISA assays, including one to the complex of S100A8/S100A9, to measure levels of 8 of the15 proteins. Validating our DIGE results, this ELISA panel correctly classified independent SJIA flare samples, and distinguished them from acute febrile illness. Notably, data using the panel suggest its ability to improve on erythrocyte sedimentation rate or C-reactive protein or S100A8/S100A9, either alone or in combination in SJIA F/Q discriminations. Our results also support the panel's potential clinical utility as a predictor of incipient flare (within 9 wk) in SJIA subjects with clinically inactive disease. Pathway analyses of the 15 proteins in the SJIA flare versus quiescence signature corroborate growing evidence for a key role for IL-1 at disease flare.
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136595      PMCID: PMC3517169          DOI: 10.1002/pmic.201000298

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  66 in total

1.  Juvenile rheumatoid arthritis: a general review and report of 100 patients observed for 15 years.

Authors:  J J Calabro; W B Holgerson; G M Sonpal; M I Khoury
Journal:  Semin Arthritis Rheum       Date:  1976-02       Impact factor: 5.532

2.  Letter: Elevation of serum C9 level associated with Behçet disease.

Authors:  S Kawachi-Takahashi; M Takahashi; M Kogure; T Kawashima
Journal:  Jpn J Exp Med       Date:  1974-10

3.  Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

Authors:  Y Yui; T Aoyama; H Morishita; M Takahashi; Y Takatsu; C Kawai
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.

Authors:  F C De Beer; R K Mallya; E A Fagan; J G Lanham; G R Hughes; M B Pepys
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

5.  Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.

Authors:  Dirk Foell; Helmut Wittkowski; Inga Hammerschmidt; Nico Wulffraat; Heinrike Schmeling; Michael Frosch; Gerd Horneff; Wietse Kuis; Clemens Sorg; Johannes Roth
Journal:  Arthritis Rheum       Date:  2004-04

6.  Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis.

Authors:  A Schulze zur Wiesch; D Foell; M Frosch; T Vogl; C Sorg; J Roth
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

Review 7.  Juvenile rheumatoid arthritis: outcome and treatment for the 1990s.

Authors:  C A Wallace; J E Levinson
Journal:  Rheum Dis Clin North Am       Date:  1991-11       Impact factor: 2.670

8.  Determination of serum C9 level by immunodiffusion. Elevation in patients with infectious or allergic skin diseases.

Authors:  S Kawachi-Takahashi; K Tanaka; M Takahashi; T Kawashima; K Shimada
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

9.  Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL.

Authors:  Weerapan Khovidhunkit; Philippe N Duchateau; Katalin F Medzihradszky; Arthur H Moser; Josefina Naya-Vigne; Judy K Shigenaga; John P Kane; Carl Grunfeld; Kenneth R Feingold
Journal:  Atherosclerosis       Date:  2004-09       Impact factor: 5.162

Review 10.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

View more
  24 in total

Review 1.  Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.

Authors:  Elizabeth D Mellins; Claudia Macaubas; Alexei A Grom
Journal:  Nat Rev Rheumatol       Date:  2011-06-07       Impact factor: 20.543

2.  Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes.

Authors:  Grant S Schulert; Ndate Fall; John B Harley; Nan Shen; Daniel J Lovell; Sherry Thornton; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

Review 3.  From bench to bedside and back again: translational research in autoinflammation.

Authors:  Dirk Holzinger; Christoph Kessel; Alessia Omenetti; Marco Gattorno
Journal:  Nat Rev Rheumatol       Date:  2015-06-16       Impact factor: 20.543

Review 4.  Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

Authors:  Courtney Crayne; Randy Q Cron
Journal:  Eur J Rheumatol       Date:  2019-12-03

5.  Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.

Authors:  Xuefeng B Ling; Kenneth Lau; Chetan Deshpande; Jane L Park; Diana Milojevic; Claudia Macaubas; Chris Xiao; Viorica Lopez-Avila; John Kanegaye; Jane C Burns; Harvey Cohen; James Schilling; Elizabeth D Mellins
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

6.  A Multiparameter Flow Cytometry Analysis Panel to Assess CD163 mRNA and Protein in Monocyte and Macrophage Populations in Hyperinflammatory Diseases.

Authors:  Sherry Thornton; Rachel Tan; Alyssa Sproles; Thuy Do; Jonathan Schick; Alexei A Grom; Monica DeLay; Grant S Schulert
Journal:  J Immunol       Date:  2019-01-25       Impact factor: 5.422

Review 7.  Macrophage activation syndrome and cytokine-directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

8.  Clinical analysis in 202 children with juvenile idiopathic arthritis.

Authors:  Hui Huang; Xiaoqing Qian; Haiguo Yu; Juan Li; Yayuan Zhang
Journal:  Clin Rheumatol       Date:  2013-03-21       Impact factor: 2.980

9.  Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis.

Authors:  David S Gibson; Keri Newell; Alexandra N Evans; Sorcha Finnegan; Gwen Manning; Caitriona Scaife; Catherine McAllister; Stephen R Pennington; Mark W Duncan; Terry L Moore; Madeleine E Rooney
Journal:  J Proteomics       Date:  2012-07-06       Impact factor: 4.044

10.  Application of the Yamaguchi criteria for classification of "suspected" systemic juvenile idiopathic arthritis (sJIA).

Authors:  Sharath Kumar; Divya Shree Kunhiraman; Lalitha Rajam
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-23       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.